Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities. International Journal of Obesity
Nature 394:780793 Baggio LL, Huang Q, Brown TJ, Drucker DJ (2004) A recombinant human glucagonlike peptide (GLP)-1albumin protein (albugon) mimics peptidergic activation of GLP-1 receptordependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis
Drawing on health records from Ontario, Canada, researchers at the University of Toronto analyzed nearly 140,000 adults with type 2 diabetes to investigate a possible link between GLP-1 use and wet AMD
This technique ensures immediate absorption and utilisation by the bodys cells
doi: 10.1016/j.jep.2016.10.003 366 Daz-de-CerioEVerardoVGmez-CaravacaAMFernndez-GutirrezASegura-CarreteroA
the latter are subjected to study in animal models for the elucidation of mechanisms leading to development and progression